Pharmaceutical company Galderma has been confirmed as a Silver Sponsor for The Aesthetics Awards 2027. Galderma will celebrate the leading clinics in the South of England through the Galderma Award
A dual approach with Sculptra® and Restylane® SkinboostersTM can help patients achieve smoother, brighter and more resilient-looking summer skin by addressing both derma structure and skin quality Summer is often associated with healthy, luminous skin, yet the season can also …
Pharmaceutical company Galderma has secured European Union approval under the Medical Device Regulation for Restylane Shaype for chin augmentation. Powered by NASHA HD technology, the injectable is indicated for deep
The Clinical Cosmetic Regenerative Congress (CCR) will bring together a two-day educational programme spanning multiple stages and formats. Sessions will take place across The Innovation Forum, the Dentists in Aesthetic
Galderma explores the role of Restylane SkinboostersTM in structured treatment cycles for deep hydration and sustained skin quality improvement For many patients, ‘good skin’ is no longer just about smoothing a line or filling a fold. Increasingly, they are asking …
Pharmaceutical company Galderma welcomed press and specialty guests to a healthcare practitioner-led Open Clinic at The Londoner Hotel on June 30. Guests were invited to undergo a personalised skin analysis
Harnessing Sculptra body to address skin quality concerns beyond the face Sculptra is made with the unique PLLA-SCA™, its proprietary form of poly-L-lactic acid (PLLA).1,2,3 Slow degradation of Sculptra’s PLLA-SCA™ provides continuous regenerative biostimulation, characterised by early onset of tissue …
Pharmaceutical company Galderma has been announced as Headline Sponsor for the Clinical Cosmetic Regenerative Congress (CCR) 2026. Galderma will have a presence across the scientific programme and exhibition floor, providing
Skincare company ALASTIN from pharmaceutical company Galderma has launched C‑Radical Defense Antioxidant Serum. According to the company, the formulation uses an encapsulated form of sodium ascorbate within a proprietary liposomal
Pharmaceutical company Galderma has released new interim data from two ongoing investigator-initiated trials (IITs). The IITs presented results from Sculptra, a regenerative biostimulator, and the hyaluronic acid injectable Restylane range
